NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has submitted to the New York State Department of Health a validation package for its newest AmpiProbe™ based assay -- designed to identify the presence of the most common species of Candida from a single vaginal swab, and the first in a panel of tests aimed at diagnosing multiple women’s infectious health issues.
